Cargando…

EASIX-1year and late mortality after allogeneic stem cell transplantation

Patients with hematological malignancies who survive the first year after allogeneic stem cell transplantation (allo-SCT) without relapse have a substantial risk of nonrelapse mortality (NRM) and missing predictive markers. The Endothelial Activation and Stress Index (EASIX) predicts endothelial com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kordelas, Lambros, Terzer, Tobias, Gooley, Ted, Davis, Chris, Sandmaier, Brenda M., Sorror, Mohamed, Penack, Olaf, Schaeper, Nigel D. E., Blau, Igor W., Beelen, Dietrich, Radujkovic, Aleksandar, Dreger, Peter, Luft, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509665/ https://www.ncbi.nlm.nih.gov/pubmed/37477588 http://dx.doi.org/10.1182/bloodadvances.2022008617

Ejemplares similares

Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel
por: Jiang, Sihe, et al.
Publicado: (2020)

Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation
por: Schwarzbich, Mark-Alexander, et al.
Publicado: (2022)

Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2019)

Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study
por: Radujkovic, Aleksandar, et al.
Publicado: (2019)

Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

EASIX for prediction of survival in lower-risk myelodysplastic syndromes
por: Merz, Almuth, et al.
Publicado: (2019)

Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
por: Korell, Felix, et al.
Publicado: (2022)

EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients
por: Luft, Thomas, et al.
Publicado: (2021)

Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
por: Dai, Hao, et al.
Publicado: (2021)

Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
por: Luft, Thomas, et al.
Publicado: (2021)

Megadose (90)Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
por: Chow, Victor A., et al.
Publicado: (2021)

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
por: Ueda Oshima, Masumi, et al.
Publicado: (2023)

Prediction of outcomes after second-line treatment for acute graft-versus-host disease
por: Vo, Phuong, et al.
Publicado: (2022)

EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy—A Cohort Study
por: Korell, Felix, et al.
Publicado: (2022)

Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome
por: Radujkovic, Aleksandar, et al.
Publicado: (2015)

Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD
por: Dai, Hao, et al.
Publicado: (2021)

Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation
por: Korell, Felix, et al.
Publicado: (2023)

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease
por: Kordelas, Lambros, et al.
Publicado: (2016)

EASIX, Modified EASIX and Simplified EASIX as an Early Predictor for Intensive Care Unit Admission and Mortality in Severe COVID-19 Patients
por: Zińczuk, Aleksander, et al.
Publicado: (2022)

An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient
por: Ibrahim, Uroosa, et al.
Publicado: (2016)

Treatment of allosensitized patients receiving allogeneic transplantation
por: Ciurea, Stefan O., et al.
Publicado: (2021)

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2023)

Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
por: Gooptu, Mahasweta, et al.
Publicado: (2022)

Type 1 interferon to prevent leukemia relapse after allogeneic transplantation
por: Magenau, John M., et al.
Publicado: (2021)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
por: Martin, Paul J., et al.
Publicado: (2022)

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023)

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
por: Chiesa, Robert, et al.
Publicado: (2022)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
por: Yeh, Jason, et al.
Publicado: (2021)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
por: Nishiwaki, Satoshi, et al.
Publicado: (2022)

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
por: Pérez-Valencia, Amanda Isabel, et al.
Publicado: (2022)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
por: Murthy, Hemant S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dkn4n1n8qinf6hps7e3l2mkd40